Shuangye Liao

Shuangye Liao

Auto-generated profile, based on publicly available information

Shuangye Liao

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2023 in Cancer Research
Verified
Journal Article
Closed access
PDF file
XZXiaomin Zhang
Xiaomin Zhang
LCLimin Cheng
Limin Cheng
CGChengqi Gao
Chengqi Gao
JCJing Chen
Jing Chen
SLShuangye Liao
Shuangye Liao
PZPenghui Zhou
Penghui Zhou
Sex is known to be an important factor in the incidence, progression, and outcome of cancer. A better understanding of the underlying mechanisms could help improve cancer prevention and treatment. Here, we demonstrated a crucial role of antitumor immunity in the sex differences in cancer. Consistent with observations in human cancers, male mice showed accelerated tumor progression compared with females, but these differences were not observed in immunodeficient mice. Androgen signaling suppressed T-cell immunity against cancer in males. Mechanistically, androgen-activated androgen receptor upregulated expression of USP18, which inhibited TAK1 phosphorylation and the subsequent activation of NF-κB in antitumor T cells. Reduction of testosterone synthesis by surgical castration or using the small-molecular inhibitor abiraterone significantly enhanced the antitumor activity of T cells in male mice and improved the efficacy of anti–PD-1 immunotherapy. Together, this study revealed a novel mechanism contributing to sex differences in cancer. These results indicate that inhibition of androgen signaling is a promising approach to improve the efficacy of immunotherapy in males. Significance: Androgen signaling induces immunosuppression in cancer by blocking T-cell activity through upregulation of USP18 and subsequent inhibition of NF-κB activity, providing a targetable axis to improve antitumor immunity in males.

9 December 2025 in Cancer Immunology Research
Verified
Journal Article
Closed access
LXLiping Xu
Liping Xu
XZXiaomin Zhang
Xiaomin Zhang
XLXiaowei Lai
Xiaowei Lai
HCHongyuan Chen
Hongyuan Chen
SLShuangye Liao
Shuangye Liao
PZPenghui Zhou
Penghui Zhou
Tumor cells employ metabolic mechanisms to limit antitumor immunity and promote resistance to immunotherapy. However, how immunotherapy modulates tumor metabolism remains unclear. In this study, we demonstrated that anti–PD-1 treatment regulated cholesterol biosynthesis in cancer cells through the effector cytokine IFNγ. Mechanistically, IFNγ-induced IRF1 transcriptionally suppresses the expression of SREBF2, a master regulator of cholesterol synthesis. Reduced cholesterol content inhibited tumor growth and sensitized tumor cells to statins, drugs that can lower cholesterol. Overall, our study reveals that IFNγ-mediated inhibition of cholesterol biosynthesis in tumor cells is an important antitumor mechanism of immunotherapy.

31 March 2023
Verified
Other
Open access
XZXiaomin Zhang
Xiaomin Zhang
LCLimin Cheng
Limin Cheng
CGChengqi Gao
Chengqi Gao
JCJing Chen
Jing Chen
SLShuangye Liao
Shuangye Liao
PZPenghui Zhou
Penghui Zhou
Clinical characteristics for melanoma cohort analyzed sex difference of survival in patients treated with anti-PD-1 antibody

31 March 2023
Verified
Other
Open access
XZXiaomin Zhang
Xiaomin Zhang
LCLimin Cheng
Limin Cheng
CGChengqi Gao
Chengqi Gao
JCJing Chen
Jing Chen
SLShuangye Liao
Shuangye Liao
PZPenghui Zhou
Penghui Zhou
Clinical characteristics for the NSCLC cohort analyzed the correlation between testosterone levels, prognosis and T cell infiltration


4 March 2026
Verified
Other
Open access
LXLiping Xu
Liping Xu
XZXiaomin Zhang
Xiaomin Zhang
XLXiaowei Lai
Xiaowei Lai
HCHongyuan Chen
Hongyuan Chen
SLShuangye Liao
Shuangye Liao
PZPenghui Zhou
Penghui Zhou
Supplementary Table 1. qRT-PCR primers of cholesterol biosynthesis genes